Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00276432 · ClinicalTrials.gov registry record · Phase 4
Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Rapid Bedside cTnl on Outcome.
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 350
- Enrollment target
NCT00276432: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT00276432 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 350 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00276432, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 350 participants
- Enrollment target
Study Summary
The primary outcome in this study will be time to discharge for low-risk patients and therapeutic turnaround time for patients with NSTEMI or unstable angina.
Interventions
- DEVICE iSTAT point of care analyzer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2005-11 |
| Est. Completion | 2007-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00276432
The ClinicalTrials.gov registry entry for NCT00276432 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iSTAT point of care analyzer is the first listed.
NCT00276432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00276432 about?
NCT00276432 is a clinical study titled "Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Rapid Bedside cTnl on Outcome.". The primary outcome in this study will be time to discharge for low-risk patients and therapeutic turnaround time for patients with NSTEMI or unstable angina.
What is the current status of trial NCT00276432?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 350 participants. The study started on 2005-11. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00276432?
The interventions under investigation include: iSTAT point of care analyzer (DEVICE).
Who is sponsoring clinical trial NCT00276432?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.